Literature DB >> 7237427

Characterization of tumorigenicity, mortality, metastasis, and splenomegaly of two cultured murine colon lines.

N Sato, M C Michaelides, M K Wallack.   

Abstract

The murine colon tumors 26 and 36 have been adapted to culture in vitro from the parental, serially transplanted tumors. The biological activities of these cultured colon lines (C-C26 and C-C36) have been characterized in vivo by s.c. inoculation of serial doses of cells into syngeneic BALB/c mice. The C-C26 line is highly tumorigenic and has a low tendency (9.1%) for metastasis to the lungs. Moreover, mice inoculated with C-C26 exhibited high mortality and normal or atrophied spleens. In contrast, the C-C36 line is less tumorigenic and highly metastatic to the lungs (77.8%). Mortality was lower in animals inoculated with C-C36, and at autopsy, splenomegaly was frequently (72.2%) observed without any visible metastatic nodules in these spleens. Metastasis to the lungs was intimately associated with splenomegaly, and death followed closely. Our findings with the C-C26 and C-C36 lines agree with those reported for the parental tumors with respect to tumorigenicity, tumor growth, and mortality. However, they differ with respect to their metastatic potential, because previous reports showed this to be higher for the serially transplanted colon 26 than the colon 36 tumor cells. Furthermore, this work describes the remarkable splenomegaly observed in mice inoculated with C-C36 but not with C-C26. This finding may in turn provide us with the opportunity to compare the functional status of the spleen in these tumor-bearing animals.

Entities:  

Mesh:

Year:  1981        PMID: 7237427

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

1.  Cyclohepta[b]thiophenes as Potential Antiproliferative Agents: Design, Synthesis, In Vitro, and In Vivo Anticancer Evaluation.

Authors:  Somaya A Abdel-Rahman; Ashraf K El-Damasy; Ghada S Hassan; Emad I Wafa; Sean M Geary; Azza R Maarouf; Aliasger K Salem
Journal:  ACS Pharmacol Transl Sci       Date:  2020-08-27

2.  Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse.

Authors:  Paola Aulino; Emanuele Berardi; Veronica M Cardillo; Emanuele Rizzuto; Barbara Perniconi; Carla Ramina; Fabrizio Padula; Enrico P Spugnini; Alfonso Baldi; Fabio Faiola; Sergio Adamo; Dario Coletti
Journal:  BMC Cancer       Date:  2010-07-08       Impact factor: 4.430

3.  Research of an in vitro model to study the expression of fatty acid-binding proteins in the small intestine.

Authors:  A Mallordy; P Besnard; H Carlier
Journal:  Mol Cell Biochem       Date:  1993 Jun 9-23       Impact factor: 3.396

4.  Fasting protects against the side effects of irinotecan treatment but does not affect anti-tumour activity in mice.

Authors:  Sander A Huisman; Peter de Bruijn; Inge M Ghobadi Moghaddam-Helmantel; Jan N M IJzermans; Erik A C Wiemer; Ron H J Mathijssen; Ron W F de Bruin
Journal:  Br J Pharmacol       Date:  2016-02-08       Impact factor: 8.739

5.  Comparison of splenectomy effects as an indication for host response to growth of primary and metastatic tumour cells in two murine tumour systems.

Authors:  M Michowitz; N Donin; J Sinai; J Leibovici
Journal:  Int J Exp Pathol       Date:  1995-02       Impact factor: 1.925

6.  Active specific immunotherapy with vaccinia colon oncolysate enhances the immunomodulatory and antitumor effects of interleukin-2 and interferon alpha in a murine hepatic metastasis model.

Authors:  P J Arroyo; J A Bash; M K Wallack
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

7.  Enhanced green fluorescent protein-transfection of murine colon carcinoma cells: key for early tumor detection and quantification.

Authors:  Jörg W Sturm; Michael A Keese; Beate Petruch; Roderich G Bönninghoff; Hongyue Zhang; Norbert Gretz; Mattias Hafner; Stefan Post; Robert S McCuskey
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

8.  Kinase inhibitor Sorafenib modulates immunosuppressive cell populations in a murine liver cancer model.

Authors:  Mengde Cao; Yiling Xu; Je-in Youn; Roniel Cabrera; Xiaokui Zhang; Dmitry Gabrilovich; David R Nelson; Chen Liu
Journal:  Lab Invest       Date:  2011-02-14       Impact factor: 5.662

9.  Folding of an MHC class II-restricted tumor antigen controls its antigenicity via MHC-guided processing.

Authors:  Yusuke Mimura; Yuka Mimura-Kimura; Katie Doores; Denise Golgher; Benjamin G Davis; Raymond A Dwek; Pauline M Rudd; Tim Elliott
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-26       Impact factor: 11.205

10.  Colony-stimulating activity from the new metastatic TS/A cell line and its high- and low-metastatic clonal derivatives.

Authors:  G Nicoletti; P Brambilla; C De Giovanni; P L Lollini; B Del Re; A Marocchi; P Mocarelli; G Prodi; P Nanni
Journal:  Br J Cancer       Date:  1985-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.